News and Announcements
Results of Liver Fibrosis Project
- Published December 21, 2012 2:26AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Resonance Health has been undertaking a project with the aim to develop an MRI based technology to detect and measure liver fibrosis. The Company has conducted a number of studies which have shown some promising results. In 2011/12, the Company undertook an additional study in collaboration with the Austin Health liver unit in Victoria to explore this further. This study has now been completed.
The results have demonstrated an ability to detect liver fibrosis with MRI but unfortunately not with sufficient accuracy or sensitivity to be competitive with other products currently available. Whilst the results were not as positive as we had hoped, they provide a level of confidence to progress the project further and we are currently exploring alternative ways to analyse the image data that may enable improved detection of fibrosis that is competitive with other products.
——
To view the full article, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
